DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy

The progression of hepatocellular carcinoma (HCC) remains a huge clinical challenge, and elucidation of the underlying molecular mechanisms is critical to develop effective therapeutic strategy. Dumbbell former 4 (DBF4) complexes with cell division cycle 7 (CDC7) to form DBF4-dependent kinase (DDK),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liang, Hong, Jiawei, Chen, Wei, Zhang, Wei, Liu, Xi, Lu, Jiahua, Tang, Hong, Yang, Zhentao, Zhou, Ke, Xie, Haiyang, Jia, Changku, Jiang, Donghai, Zheng, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367558/
https://www.ncbi.nlm.nih.gov/pubmed/37497004
http://dx.doi.org/10.7150/ijbs.80351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367558/
https://www.ncbi.nlm.nih.gov/pubmed/37497004
http://dx.doi.org/10.7150/ijbs.80351

Ejemplares similares